MDIC Publishes First MedTech Cybersecurity Maturity Benchmarking Report
The benchmarking effort from MDIC will serve as a tool and a resource towards identifying…
News
AI Metrics Raises $1.26 MM to Accelerate Innovation and R&D for its AI-enabled Cancer Imaging Technology
Bridge Round Investment Supported by Angel Fund and Individual Investors BIRMINGHAM, Ala.–(BUSINESS WIRE)–AI Metrics, an…
Manhattan Associates Reports Record Third Quarter Results
RPO Bookings Increase 69% over Prior Year on Strong Demand Company Raises 2022 Full-Year Revenue…
Redgate upgrades SQL Monitor query tuning capability to help development teams move faster and smarter
As part of its ongoing program to continuously release improvements for its SQL Server performance…
ProLion Ensures Data And Service Continuity For The University Of Bonn After Power Outage
ProLion’s ClusterLion solution intervenes to prevent data loss and downtime after air conditioning failure in…
GBS Inc. Initiates Company Name Change to Intelligent Bio Solutions Inc. (IBSS) and Announces Key Executive Appointments
– Name change to more closely reflect firm’s expanding portfolio of intelligent, efficient, convenient and…
CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., Oct….
PLx Pharma Inc. to Report Third Quarter 2022 Financial Results on November 11, 2022, and Provide Business Update
SPARTA, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the…
ICSI outcomes unchanged in men with normal or abnormal Cap-Scores™
ICSI fertilization rates and subsequent pregnancy rates were not different between men with normal or…
The Cap-Score™ is a more sensitive indicator of male fertility across age groups than traditional semen analysis
New study demonstrates the value of using the Cap-Score Test to assess the fertilizing ability…
Allogene Therapeutics to Report Third Quarter 2022 Financial Results on November 2, 2022
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Oct. 26, 2022 (GLOBE…
Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022
CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Acer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering EDSIVO™ (celiprolol)
Notice of allowance of celiprolol method of treatment of vEDS patent application strengthens proprietary position…
Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022
On October 23, 2022, Sumitovant Biopharma Ltd. (Sumitovant), in conjunction with parent company Sumitomo Pharma…
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems
VANCOUVER, British Columbia, Oct. 26, 2022 (GLOBE NEWSWIRE) — Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has signed…
INmune Bio, Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on Wednesday, November 2
Management to host conference call and webcast at 4:30 pm ET on that day Boca…
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
BOTHELL, Wash., Oct. 26, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the…
scPharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 9, 2022
BURLINGTON, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
X4 Pharmaceuticals Announces Appointment of Industry Veteran Mark Baldry as Chief Commercial Officer
A seasoned leader in the launch of rare and specialty pharmaceuticals, Mr. Baldry is expected…